WhiteOak Capital Pharma and Healthcare Fund
- NAV
- ₹17.44
- —30 Oct 2026
- AUM (₹ Cr)
- 858
- Average, July - September 2026
- Expense ratio
- 1.07%
- Regular 2.72%
- Risk
- Very High
- SEBI riskometer
- 1Y return
- 19.6%+8.7%
- Benchmark 10.8%
- 3Y CAGR
- —
- Category 22.4%
- 5Y CAGR
- —
- Category 16.1%
Rank in category
Too young for a combined rank, which needs five years. On its 1-year return it is #3 of 17.
Ranked on 1Y, 3Y and 5Y together. 8 of 19 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily NAVs. Risk-free rate 6.5% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +0.9% | +0.9% | +18.0% | +22.8% | +19.6% | — | — | — | +22.3% |
| BSE Healthcare TRI | — | — | — | — | 10.8% | — | — | — | 14.8% |
| Healthcare average | -0.3% | -0.9% | 13.5% | 16.7% | 14.5% | 22.4% | 16.1% | 14.7% | 16.3% |
| Difference | — | — | — | — | +8.7% | — | — | — | +7.6% |
Portfolio
Valuation
- P/E
- 54.3
- Covers 96% of its shares
- Category median
- 48.4
- 19 Healthcare funds
- Benchmark P/E
- 44.3
- BSE Healthcare
P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 21 Oct 2026. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.
Fund details
- Fund house
- WhiteOak Capital Mutual Fund
- Category
- Equity · Healthcare
- SEBI classification
- Equity / Sectoral / Thematic
- Benchmark
- BSE Healthcare TRI
- Launch date
- 7 Feb 2024 (2.7 years)
- Structure
- Open Ended
- Plans and options
- Direct Growth, Regular Growth
- Fund manager
- Ramesh Mantri
- Minimum SIP
- ₹100
- Minimum lumpsum
- ₹500 (then ₹500)
- Exit load
- None
- Lock-in
- None
- Riskometer
- Very High (benchmark Very High)
- Expense ratio as of
- 29 Oct 2026
- AUM period
- July - September 2026
- ISIN, Direct Growth
- INF03VN01886
- ISIN, Regular Growth
- INF03VN01878
- Scheme code
- 152349, 152348
NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.
Other healthcare funds
Other funds in the Healthcare category.
- Kotak Healthcare FundKotak Mahindra Mutual Fund · ₹743 Cr · ER 1.03%
- Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas Mutual Fund · ₹511 Cr · ER 1.47%
- quant Healthcare Fundquant Mutual Fund · ₹412 Cr · ER 1.62%
- Bajaj Finserv Healthcare FundBajaj Finserv Mutual Fund · ₹389 Cr · ER 0.90%
- Bandhan Healthcare FundBandhan Mutual Fund · ₹325 Cr · ER 1.25%
- ITI Pharma and Healthcare FundITI Mutual Fund · ₹266 Cr · ER 0.89%